#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Endo names COO of Pharmaceuticals

Share on Twitter Share on LinkedIn
Staff writer | Malvern, Pa., USA | July 23, 2013
Don DeGolyerJuly 23, 2013, Malvern, Pa., USA - Endo Health Solutions Inc., a diversified healthcare company, announced the appointment of Don DeGolyer as COO, Pharmaceuticals, which includes Endo Pharmaceuticals and Qualitest, effective August 1, 2013.
Most recently, Mr. DeGolyer served as President and CEO of Sandoz Inc., Novartis' North America generic pharmaceuticals unit. Prior to joining Novartis in 2002, he spent 11 years at Johnson & Johnson in various roles of increasing responsibility, including Vice President of Marketing and Sales, and began his career at Pfizer, Inc.

He has been Vice Chairman of Generic Pharmaceutical Association since February 2012. Mr. DeGolyer received a Bachelor of Arts degree in Political Science from University of Rochester as well as an MBA in Marketing from Fairleigh Dickinson University.


 LATEST MOVES FROM Pennsylvania 


MORE INSIDE POST